Sophisticated lipidomics analyses revealed that Gdpd3 deficiency reduced levels of certain lysophosphatidic acids (LPAs) and lipid mediators in CML cells. Here, GDPD3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.